The H2 Antagonists market size is expected to reach $25.14 billion in 2030 at a CAGR of 6.5%, driven by increasing gastrointestinal disorders.
Read More
The H1N1 Vaccine market size is expected to reach $5.05 billion in 2030 at a CAGR of 7.5%, driven by rising chronic disease prevalence.
Read More
The Gynecology Drugs market size is expected to reach $58.79 billion in 2030 at a CAGR of 5.5%, driven by rising ovarian cancer cases.
Read More
The Gynecological Cancer Drugs market size is expected to reach $21.3 billion in 2030 at a CAGR of 6.8%, driven by high cancer prevalence.
Read More
The Gummy Vitamins market size is expected to reach $12.75 billion in 2030 at a CAGR of 8.3%, driven by increasing vegan population.
Read More
The Guillain-Barre Syndrome Drugs market size is expected to reach $1.73 billion in 2030 at a CAGR of 6.5%, driven by rising autoimmune disorders.
Read More
The Grand Mal Seizure Treatment market size is expected to reach $2.76 billion in 2030 at a CAGR of 5.9%, driven by high prevalence of epilepsy.
Read More
The GnRH Receptor Antagonists market size is expected to reach $2.38 billion in 2030 at a CAGR of 8.5%, driven by increasing prevalence of hormone-related disorders.
Read More
The GnRH Agonists And Antagonists Drugs market size is expected to reach $2.72 billion in 2030 at a CAGR of 9.4%, driven by increasing ovarian and prostate cancers.
Read More
The Glycopeptide Antibiotics market size is expected to reach $5.89 billion in 2030 at a CAGR of 9.3%, driven by increasing prevalence of gram-positive infections.
Read More